| AnaSpec |
AS-60210-5 |
DNA-PK Substrate
|
5 mg |
|
|
| AnaSpec |
AS-60211-5 |
ERKtide
|
5 mg |
|
|
| AnaSpec |
AS-29942-1 |
EGFR Protein Tyrosine Kinase Substrate [ADEYLIPQQ]
|
1 mg |
|
|
| AnaSpec |
AS-29945-1 |
AKT/PKB/Rac-Protein Kinase Substrate [ARKRERTYSFGHHA], Biotinylated
|
1 mg |
|
|
| AnaSpec |
AS-29945-5 |
AKT/PKB/Rac-Protein Kinase Substrate [ARKRERTYSFGHHA], Biotinylated
|
5 mg |
|
|
| AnaSpec |
AS-29972-1 |
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated
|
1 mg |
|
|
| AnaSpec |
AS-60017-1 |
Beta-Amyloid (11-40), Human
|
1 mg |
|
|
| AnaSpec |
AS-60023-1 |
TAT (47-57)
|
1 mg |
|
|
| AnaSpec |
AS-60023-5 |
TAT (47-57)
|
5 mg |
|
|
| AnaSpec |
AS-60026-1 |
PKTPKKAKKL
|
1 mg |
|
|
| AnaSpec |
AS-60084-1 |
Beta-Amyloid (9-42), Human
|
1 mg |
|
|
| AnaSpec |
AS-60134-1 |
[D-Tyr6, ß-Ala11, Phe13, Nle14]-Bombesin (6-14)
|
1 mg |
|
|
| AnaSpec |
AS-60167-5 |
SAMS Peptide
|
5 mg |
|
|
| AnaSpec |
AS-29877 |
MBP, MAPK Substrate, Biotinylated, Phosphorylated
|
1 mg |
|
|
| AnaSpec |
AS-28319 |
CEF10, Epstein-Barr Virus LMP2 (426-434)
|
1 mg |
|
|
| AnaSpec |
AS-28320 |
CEF11, Epstein-Barr Virus BMLF1 (280-288)
|
1 mg |
|
|
| AnaSpec |
AS-28327 |
CEF19, Epstein-Barr Virus latent NA-3A (458-466)
|
1 mg |
|
|
| AnaSpec |
AS-28328 |
CEF20, Cytomegalovirus, CMV pp65 (495-503)
|
1 mg |
|
|
| AnaSpec |
AS-28333 |
CEF25, Influenza Virus NP (44-52)
|
1 mg |
|
|
| AnaSpec |
AS-28334 |
CEF26, Influenza Virus NP (265-274)
|
1 mg |
|
|
| AnaSpec |
AS-28338 |
CEF30, Epstein-Barr Virus BRLF1 (134-142)
|
1 mg |
|
|
| AnaSpec |
AS-29211 |
MBP (87-99), human
|
1 mg |
|
|
| AnaSpec |
AS-29213 |
[Ser140]-PLP (139-151)
|
1 mg |
|
|
| AnaSpec |
AS-25346 |
Hepatitis Virus C NS3 Protease Inhibitor 2
|
1 mg |
|
|
| AnaSpec |
AS-25365 |
Beta-Amyloid (10-20), Human
|
1 mg |
|
|
| AnaSpec |
AS-27018 |
CREBtide [KRREILSRRPSYR], Phosphorylated, C-term K
|
1 mg |
|
|
| AnaSpec |
AS-27024 |
OVA (323-339)
|
1 mg |
|
|
| AnaSpec |
AS-27025 |
OVA (323-339)
|
5 mg |
|
|
| AnaSpec |
AS-27069 |
W Peptide, WKYMVm - NH2
|
1 mg |
|
|
| AnaSpec |
AS-27076 |
390 MMP FRET Substrate I
|
1 mg |
|
|
| AnaSpec |
AS-27077 |
390 MMP FRET Substrate I
|
5 mg |
|
|
| AnaSpec |
AS-27079 |
390 MMP FRET Substrate II
|
5 mg |
|
|
| AnaSpec |
AS-27094 |
360 MMP FRET Substrate III
|
1 mg |
|
|
| AnaSpec |
AS-27109 |
390 MMP FRET Substrate IV
|
5 mg |
|
|
| AnaSpec |
AS-27114 |
NFF-3
|
1 mg |
|
|
| AnaSpec |
AS-27168 |
MBP MAPK Substrate
|
5 mg |
|
|
| AnaSpec |
AS-27176 |
Neurogranin 28-43 [AAKIQASFRGHMARKK], Biotinylated-LC
|
5 mg |
|
|
| AnaSpec |
AS-27183 |
ERMRPRKRQGSVRRRV
|
1 mg |
|
|
| AnaSpec |
AS-27191 |
S6 Kinase Substrate (229-239)
|
1 mg |
|
|
| AnaSpec |
AS-27192 |
S6 Kinase Substrate (229-239)
|
5 mg |
|
|
| AnaSpec |
AS-27193 |
S6 Kinase Substrate (229-239), Amide, Biotinalyted
|
1 mg |
|
|
| AnaSpec |
AS-28231 |
Biotin-LC-MBP Derivatized Peptide
|
1 mg |
|
|
| AnaSpec |
AS-28232 |
Biotin-LC-MBP Derivatized Peptide
|
5 mg |
|
|
| AnaSpec |
AS-28310 |
CEF1, Influenza Matrix Protein M1 (58-66)
|
1 mg |
|
|
| AnaSpec |
AS-28311 |
CEF2, Influenza Virus PA (46-54)
|
1 mg |
|
|
| AnaSpec |
AS-28317 |
CEF8, Influenza Virus NP (383-391)
|
1 mg |
|
|
| AnaSpec |
AS-24627 |
[Lys8,9]-Neurotensin (8-13)
|
5 mg |
|
|
| AnaSpec |
AS-24475 |
Sauvagine
|
0.5 mg |
|
|
| AnaSpec |
AS-24520 |
Angiotensin II Substrate
|
1 mg |
|
|
| AnaSpec |
AS-24546 |
Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Phosphorylated
|
1 mg |
|
|